Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial ...

An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

Despite a constantly changing global position, Business Editor Alan Healy reports on Ireland's enduring appeal as a location ...

Proteins are the workhorses that keep our cells running, and there are many thousands of types of proteins in our cells, each performing a specialized ...

As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...

Terrain Biosciences launches from stealth today as the world's first RNA design-build company, using advanced AI and its ...

As Generative AI continues to evolve, Panda emphasized that the focus must shift from building better models to ensuring they ...